These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27919710)

  • 1. The transcription factor carbohydrate-response element-binding protein (ChREBP): A possible link between metabolic disease and cancer.
    Iizuka K
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):474-485. PubMed ID: 27919710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flightless I homolog negatively regulates ChREBP activity in cancer cells.
    Wu L; Chen H; Zhu Y; Meng J; Li Y; Li M; Yang D; Zhang P; Feng M; Tong X
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2688-97. PubMed ID: 24055811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress on the role of ChREBP in glucose and lipid metabolism.
    Iizuka K
    Endocr J; 2013; 60(5):543-55. PubMed ID: 23604004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.
    Iizuka K; Horikawa Y
    Endocr J; 2008 Aug; 55(4):617-24. PubMed ID: 18490833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transcription factor ChREBP – the coordinator of carbohydrate and lipid metabolism].
    Krawczak J; Owczarek A; Winiarska K
    Postepy Biochem; 2020 Mar; 66(1):30-37. PubMed ID: 33320482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation and role of carbohydrate response element-binding protein in metabolic homeostasis and disease.
    Jois T; Sleeman MW
    J Neuroendocrinol; 2017 Oct; 29(10):. PubMed ID: 28370553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Protective Role of the Carbohydrate Response Element Binding Protein in the Liver: The Metabolite Perspective.
    Agius L; Chachra SS; Ford BE
    Front Endocrinol (Lausanne); 2020; 11():594041. PubMed ID: 33281747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of HNF-4α as a key transcription factor to promote ChREBP expression in response to glucose.
    Meng J; Feng M; Dong W; Zhu Y; Li Y; Zhang P; Wu L; Li M; Lu Y; Chen H; Liu X; Lu Y; Sun H; Tong X
    Sci Rep; 2016 Mar; 6():23944. PubMed ID: 27029511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases.
    Iizuka K
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells.
    Kibbe C; Chen J; Xu G; Jing G; Shalev A
    J Biol Chem; 2013 Aug; 288(32):23194-202. PubMed ID: 23803610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
    Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
    J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes.
    Caron S; Huaman Samanez C; Dehondt H; Ploton M; Briand O; Lien F; Dorchies E; Dumont J; Postic C; Cariou B; Lefebvre P; Staels B
    Mol Cell Biol; 2013 Jun; 33(11):2202-11. PubMed ID: 23530060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of glucose-6-phosphate and xylulose-5-phosphate in the regulation of glucose-stimulated gene expression in the pancreatic β cell line, INS-1E.
    Iizuka K; Wu W; Horikawa Y; Takeda J
    Endocr J; 2013; 60(4):473-82. PubMed ID: 23257733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity.
    Zhang S; Guo F; Yu M; Yang X; Yao Z; Li Q; Wei Z; Feng K; Zeng P; Zhao D; Li X; Zhu Y; Miao QR; Iwakiri Y; Chen Y; Han J; Duan Y
    J Hepatol; 2020 Dec; 73(6):1482-1495. PubMed ID: 32738448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation.
    Lei Y; Zhou S; Hu Q; Chen X; Gu J
    Sci Rep; 2020 Mar; 10(1):4233. PubMed ID: 32144313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism.
    Iizuka K
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28241431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation.
    Dentin R; Benhamed F; Pégorier JP; Foufelle F; Viollet B; Vaulont S; Girard J; Postic C
    J Clin Invest; 2005 Oct; 115(10):2843-54. PubMed ID: 16184193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate response element-binding protein regulates lipid metabolism via mTOR complex1 in diabetic nephropathy.
    Chen N; Mu L; Yang Z; Du C; Wu M; Song S; Yuan C; Shi Y
    J Cell Physiol; 2021 Jan; 236(1):625-640. PubMed ID: 32583421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glucose-sensing transcription factor ChREBP is targeted by proline hydroxylation.
    Heidenreich S; Weber P; Stephanowitz H; Petricek KM; Schütte T; Oster M; Salo AM; Knauer M; Goehring I; Yang N; Witte N; Schumann A; Sommerfeld M; Muenzner M; Myllyharju J; Krause E; Schupp M
    J Biol Chem; 2020 Dec; 295(50):17158-17168. PubMed ID: 33023907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ChREBP downregulates SNAT2 amino acid transporter expression through interactions with SMRT in response to a high-carbohydrate diet.
    Velázquez-Villegas L; Noriega LG; López-Barradas AM; Tobon-Cornejo S; Méndez-García AL; Tovar AR; Torres N; Ortiz-Ortega VM
    Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E102-E112. PubMed ID: 33225719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.